Bio-Techne Corporation (TECH) stock analysis
In our weekly check, Bio-Techne Corporation is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 16 pass, warnings: 7, red flags: 2.
About Bio-Techne Corporation
Bio-Techne Corporation is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as TECH.
What our checks show for TECH
Red flags
- The net margin fell by 10.6 points over 5 years, to 14%: the company keeps less of each sale as profit.
- The stock has fallen as much as 68% from a peak. Would you have held through that?
Warning signs
- The gross margin fell by 2.7 points, to 65.8%: costs are rising faster than prices.
- Revenue grew only 2.6% a year over the last 3 years.
- Earnings per share fell 15.3% a year over the last 3 years.
- Net profit fell 15.5% a year over the last 3 years.
- The price swings a lot: 42.7% annual volatility. Expect large ups and downs.
- The stock is still below its previous peak.
- Beta 1.27: the stock usually moves more than the market, both up and down.
Strengths
- Debt is low: 0.13x equity.
- Operating profit covers interest 51.9 times over.
- Operating cash flow is 1.96x net profit: the profit arrives as real cash.
- Analysts expect earnings per share to grow about 33.8% a year over the next years.
- Analysts expect the net margin to improve by 10.1 points from today's 14%.
- Free cash flow is 25.1% of revenue: cash for dividends, buybacks or growth.
Next earnings report: 2027-02-02
Similar companies
HALO · SMMT · BMRN · KYMR · PCVX · MDGL
Questions
What grade does Bio-Techne Corporation (TECH) have?
In our weekly check, Bio-Techne Corporation is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 16 pass, warnings: 7, red flags: 2. The grade is a risk check, not a buy or sell recommendation.
What are the main risks of TECH stock?
This week's biggest flags for Bio-Techne Corporation: Margins falling, Deep past fall, Gross margin falling. In total 9 of 25 checks show a warning or a red flag.
What does Bio-Techne Corporation do?
Bio-Techne Corporation is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as TECH.
When does Bio-Techne Corporation report earnings next?
The next earnings report is expected on 2027-02-02. We re-run the checks every week, so the grade can change after it.
The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.
Updated 2026-11-14
Open the full analysis